Novo Nordisk A/S (NVO) Stock: Revenue, Earnings, Margins & Valuation
Novo Nordisk A/S (NVO), Denmark at a glance: revenue structure, segments, costs, margins and earnings from the latest published annual report (FY 2025), visualised as a Sankey diagram and complemented by price chart, P/E valuation and the original SEC filings. All figures in DKK. Free and without signup.
Novo Nordisk A/S key figures (FY 2025)
| Revenue | 309.06 DKK bn |
|---|---|
| Gross profit | 250.28 DKK bn |
| Gross margin | 81.0 % |
| Operating income | 127.66 DKK bn |
| Operating margin | 41.3 % |
| Net income | 102.43 DKK bn |
| Net margin | 33.1 % |
Novo Nordisk A/S revenue by segment (FY 2025)
| Segment | Revenue | Share |
|---|---|---|
| Diabetes and Obesity care | 289.46 DKK bn | 93.7 % |
| Rare disease | 19.61 DKK bn | 6.3 % |
Novo Nordisk A/S earnings analysis
In the latest reported fiscal year (FY 2025), Novo Nordisk A/S generated revenue of 309.06 DKK bn. The largest segment is Diabetes and Obesity care with 289.46 DKK bn, about 93.7 % of total segment revenue. From gross margin (81.0 %) through operating margin (41.3 %) to net margin (33.1 %), the Sankey diagram shows how much of each revenue dollar remains at each stage of the income statement.
Novo Nordisk A/S business model
The income statement of Novo Nordisk A/S is visualised as a Sankey diagram: from revenue through cost of revenue and operating expenses to net income. The page also shows the price chart, the price-earnings ratio of the last five fiscal years, return on equity and the company's annual and quarterly filings.
More stock analyses like Novo Nordisk A/S
- Novartis AG stock (NVS)
- NVIDIA Corporation stock (NVDA)
- NextEra Energy Inc. stock (NEE)
- Oracle Corporation stock (ORCL)
- Netflix Inc. stock (NFLX)
- Palantir Technologies stock (PLTR)
- Nestlé S.A. stock (NESN.SW)
- PepsiCo Inc. stock (PEP)
- Morgan Stanley stock (MS)
- Philip Morris International stock (PM)